Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 9 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Theodoridou, Stamatia  [Clear All Filters]
Journal Article
Theodoridou, S., Balassopoulou A., Boutou E., Delaki E-E., Yfanti E., Vyzantiadis T-A., et al. (2020).  Coinheritance of Triplicated Alpha-Globin Gene and Beta-Thalassemia Mutations in Adulthood: Ten Years of Referrals in Northern Greece.. J Pediatr Hematol Oncol. 42(8), e762-e764.
Theodoridou, S., Teli A., Yfanti E., Vyzantiadis T-A., Theodoridis T., & Economou M. (2018).  Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -α/αα Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling.. Hemoglobin. 42(2), 129-131.
Theodoridou, S., Vyzantiadis T., & Theodoridis T. (2010).  Compound heterozygosity for hemoglobin E-Saskatoon and ß-thalassemia.. J Obstet Gynaecol Res. 36(5), 1148.
Theodoridou, S., Vyzantiadis T-A., & Vlachaki E. (2018).  Compound Heterozygosity for Silent Cap +1570 (T>C) (HBB: c*96T>C), Codon 39 (C>T) (HBB: c.118C>T) and the Presence of ααα/αα in Greece. A Case Presentation.. Hemoglobin. 42(3), 194-195.
Theodoridou, S., Prapas N., Balassopoulou A., Boutou E., Vyzantiadis T-A., Adamidou D., et al. (2018).  Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants.. Hemoglobin. 42(4), 257-263.
Theodoridou, S., Delaki E., Skatharoudi E., Karakasidou O., Vyzantiadis T-A., Theodoridis T., et al. (2018).  First Report of a Coincidental Discovery of Hb Shimonoseki [α54(E3)Gln→Arg, HBA2: c.164A > G (or HBA1)] in a Greek Family.. Hemoglobin. 42(4), 281-282.
Stratopoulos, A., Kolliopoulou A., Karamperis K., John A., Kydonopoulou K., Esftathiou G., et al. (2019).  Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients.. Pharmacogenomics. 20(11), 791-801.
Sousos, N., Adamidou D., Klonizakis P., Agapidou A., Theodoridou S., Spanos G., et al. (2017).  Presence of the IVS-I-6-Mutated Allele in Beta-Thalassemia Major Patients Correlates with Extramedullary Hematopoiesis Incidence.. Acta Haematol. 137(3), 175-182.
Kolliopoulou, A., Siamoglou S., John A., Sgourou A., Kourakli A., Symeonidis A., et al. (2019).  Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study.. Hemoglobin. 43(1), 27-33.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.